Tudor Jovin, MD is an expert in interventional and non-interventional treatment for the entire spectrum of stroke and cerebrovascular disorders. He was one of the nation’s first interventional neurologists, a medical subspecialty that uses minimally invasive technologies applied from within the vessels to diagnose and treat diseases of the arteries and veins of the head, neck, and spine such as acute stroke, carotid stenosis, intracranial aneurysm, and arteriovenous malformations.

In addition to his clinical experience, Dr. Jovin is known internationally for his research activities. He has served as principal investigator for several international clinical studies including REVASCAT, a randomized trial of endovascular therapy versus medical therapy for acute stroke within eight hours of symptoms onset conducted in Spain, and DAWN, a multicenter, international, randomized trial of endovascular therapy versus medical therapy in the beyond eight-hour time window. Both studies are considered landmark studies in the development of treatments for acute stroke and have been published in the New England Journal of Medicine. He is a member of the executive or steering committees for several multicenter national and international trials, and has participated as site principal investigator or co-investigator in multiple national and international trials.

Additionally, he serves as editorial board member for numerous medical journals. Dr. Jovin has published more than 300 articles in peer-reviewed journals or book chapters. The consequential nature of his research is evidenced by recently published studies that have identified Dr. Jovin as the highest impact author in the neuro-interventional field.

Prior to joining Cooper, Dr. Jovin was a professor of neurology and neurosurgery at the University of Pittsburgh School of Medicine and director of the Center for Neuroendovascular Therapy at the University of Pittsburgh Medical Center (UPMC). At UPMC, he also served as the director of UPMC’s Stroke Institute, one of the leading centers for stroke care, education, and research in the world.

Badal R. Juneja, PhD, DABR is a board-certified Medical Physicist at MD Anderson Cancer Center at Cooper. Dr. Juneja joined Cooper in 2016 after finishing his residency at the University of Texas MD Anderson Cancer Center in Houston. He earned his Ph.D. at the University of Florida in Gainesville under Dr. Frank Bova. Outside of his clinical responsibilities, Dr. Juneja enjoys figuring out how to use technology to make patient care more efficient and effective. He played a major role in automating several routine clinical tasks at Cooper. He has a strong passion for quality assurance activities and loves to solve problems in the clinic. He is currently looking at data-mining the record-and-verify system to assess areas where clinical practice can be improved.

Among his awards and honors: Southwest AAPM Young Investigator (2015), Lawrence Fitzgerald Award for Florida AAPM (2013), and American Nuclear Society Undergraduate Design Competition (2009).

Paul Karagiannis, MD, is an Assistant Professor of Emergency Medicine at Cooper Medical School of Rowan University. After graduating from Villanova University with a degree in chemistry and a minor in political science, he earned his medical degree from Jefferson Medical College. He went on to complete his emergency medicine residency at Cooper University Hospital and he joined as a faculty member at Cooper immediately after residency.  He also works at Inspira Medical Center Mannington and serves as the Medical Director.